HomeOur workCurrent research projectsPreventing heart attacks triggered by stressors

Preventing heart attacks triggered by stressors

Enlarge font
LargeSmall

There is evidence that some heart attacks can be abruptly triggered by certain stressors. Cardiologist Geoffrey Tofler heads a team that is researching ways to use this knowledge and save lives.

 

Much research has been done on long-term risk factors for heart disease, such as cholesterol and hypertension. But there is less understanding of short-term changes that occur just before a heart attack. 

Professor Tofler and his research team

The research team (from left): Monica Spinaze (RN), Dr Elizabeth Shaw, Professor Geoffrey Tofler, Dr Tom Buckley. 

 

This area of enquiry has been a long-standing interest of preventative cardiologist Geoffrey Tofler. His study of immediate risk factors is known as TARP (Triggered Acute Risk Prevention).

 

Prevention with a single dose

The project investigates the feasibility of using a single dose of medication when there is an increased risk from certain triggers, in particular:

 

  • heavy physical exertion
  • severe emotional stress
  • a heavy meal
  • respiratory infection

 

Medication includes familiar treatments such as aspirin and beta-blockers (common heart drugs).

 

Seventeen healthy volunteers enrolled in the first phase of the study (known as TARP I). After careful instruction, they took specific medication just before or at the time of an acute triggering activity.   


Results

Preliminary results show that the volunteers reliably documented triggers and took their medication. Findings included reduced heart rate during physical exertion, compared to when not taking the therapy. 

 

Over two-thirds said it was feasible to continue taking medication in this way.

 

The results show that:

 

  • potential triggers of acute cardiovascular disease can be reliably identified
  • it is feasible and acceptable to take targeted medication at the time of these triggers.

Benefits 

The research could lead to a larger study on this method, to assess its ability to prevent cardiovascular disease. The novel treatment method could complement current long-term prevention approaches. If successful, it could have a major impact on preventing heart disease and stroke in the community. 

Further study

In the second phase (TARP II) the team is investigating this approach with individuals who have cardiovascular risk factors.

View the original research abstract

Giving HEART to future generations